InsidersTradesSigma
Discover the complete record of transactions filed by OMSTEAD DANIEL R, Président. Director active across 1 companies, notably Tekla Life Sciences Investors. In total, 2 reports have been published. Total volume traded: €236k. The latest transaction was filed on 11 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Daniel R. Omstead is the President of Tekla Life Sciences Investors. He is responsible for managing and directing investments in the life sciences sector. His investment expertise is essential for maximizing the performance of Tekla's portfolio.